theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Primary Care

Scleroderma   

Questions discussed in this category


Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
Do you generally feel they work well? Have patients tried using this a few days before an activity, such as skiing? Especially for otherwise healthy, ...
1 Answer available

How do you counsel patients on the use of topical nitroglycerin for Raynaud's?
What formulation of topical nitroglycerin do you use?
1 Answer available

How do you monitor a patient with scleroderma during pregnancy?
1 Answer available

When do you consider vascular imaging in patients with Raynaud's and what type of imaging modalities do you utilize?
1 Answer available
22655157721374413184


Papers discussed in this category


Arthritis Rheum,
Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.

Related Topics in Primary Care

  • Lung Cancer
  • Workload
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers

Copyright © 2025 theMednet
All Rights Reserved.